Close
4

Evonik Evonik

X

Company profile for CinPhloro Pharma

  • Webinars & Exhibitions

PharmaCompass
About the Company
Related CompaniesRelated Companies
CinPhloro Pharma, a part of the CinRx portfolio, is committed to developing the initial safe, effective, and long-term treatment option for irritable bowel syndrome with predominant diarrhea (IBS-D). The company's innovative formulation, CIN-103, utilizes phloroglucinol, a small molecule approved in certain countries for alleviating symptoms of functional GI disorders. CIN-103 has been modified to address the limitations of ph...
CinPhloro Pharma, a part of the CinRx portfolio, is committed to developing the initial safe, effective, and long-term treatment option for irritable bowel syndrome with predominant diarrhea (IBS-D). The company's innovative formulation, CIN-103, utilizes phloroglucinol, a small molecule approved in certain countries for alleviating symptoms of functional GI disorders. CIN-103 has been modified to address the limitations of phloroglucinol, such as its short half-life. The formulation is designed to target multiple action points in IBS-D, including motility, secretion, pain, spasms, and inflammation.

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
CinPhloro Pharma
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
Cincinnati, Ohio 45227
Telephone
Telephone
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY